3644 results for «2684»

Filter By

3644 results

Innovating heart failure care: from real-time monitoring to mechanical support

18 May 2026 – From EuroPCR 2026

Innovations in heart failure care are transforming patient management, from real-time, non-invasive congestion monitoring to advanced mechanical support systems. This session presents the Anusar congestion assessment tool, early clinical data on the NuPulse intravascular ventricular assist system for ambulatory support, and explores AI-driven voice biomarker technology...

Landmark interventional randomised controlled trial data and practice guidelines to transform pulmonary embolism care

19 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session presents landmark randomised controlled trial data shaping interventional treatment of pulmonary embolism, with a focus on translating evidence into clinical practice.

It reviews the HI-PEITHO trial and its implications in intermediate-risk acute PE, where ultrasound-assisted catheter-directed thrombolysis (USCDT) reduced the composite endpoint of...

Landmark interventional randomised controlled trial data and practice guidelines to transform pulmonary embolism care

Once you find microvascular disease, what do you actually do?

18 May 2026 – From EuroPCR 2026

Addressing coronary microvascular disease requires a comprehensive understanding of current medical therapies and emerging interventions. This session reviews state-of-the-art pharmacological treatments, elucidates the mechanisms and clinical data surrounding the coronary sinus reducer (CSR), and offers critical discussion on its therapeutic role in microvascular dysfunction.

Early evidence from a next generation coronary sinus reducer for the treatment of coronary microvascular dysfunction

20 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session presents early clinical experience with a next-generation self-expanding nitinol coronary sinus reducer for patients with coronary microvascular dysfunction. It reviews practical aspects of device implantation and discusses initial findings from the SERRA I feasibility study, providing insight into this emerging therapeutic approach....

Early evidence from a next generation coronary sinus reducer for the treatment of coronary microvascular dysfunction

Closing lectures

18 May 2026 – From EuroPCR 2026

This session presents comprehensive closing lectures focusing on the evolving understanding of coronary microvascular dysfunction, examining the balance between vulnerability and physiology, and outlining future priorities for next-generation cathlab practices. It concludes with a session evaluation and synthesis of key learnings to inform clinical practice.

Breaking the calcium challenge: the power of Hertz with LithiX intravascular lithotripsy

20 May 2026 – From EuroPCR 2026

Calcified coronary lesions remain a major challenge in PCI, particularly when lesion rigidity limits device delivery and optimal stent expansion.

This EuroPCR 2026 session focuses on contemporary calcium modification strategies and the role of the Hertz contact intravascular lithotripsy (HC-IVL) system in simplifying treatment of complex calcified...

Breaking the calcium challenge: the power of Hertz with LithiX intravascular lithotripsy

High definition IVUS-guided treatment strategies in calcified stenoses

20 May 2026 – From EuroPCR 2026

Severely calcified coronary stenoses remain one of the most challenging subsets in contemporary PCI, requiring precise lesion assessment and tailored treatment strategies.

This EuroPCR 2026 session focuses on how high-definition intravascular ultrasound (IVUS) is changing the way these lesions are approached in daily practice.

HD-IVUS enables detailed detection...

High definition IVUS-guided treatment strategies in calcified stenoses

Evidence in action: advancing care for angina with Shockwave Reducer

20 May 2026 – From EuroPCR 2026

Despite major advances in coronary revascularisation and medical therapy, angina continues to represent a significant clinical burden, affecting both quality of life and long-term patient management.

This EuroPCR 2026 session explores the emerging role of the Shockwave Reducer as a therapeutic option in patients with persistent angina....

Evidence in action: advancing care for angina with Shockwave Reducer

DK Score Pro in focus: innovation, evidence, and everyday practice

20 May 2026 – From EuroPCR 2026

Watch this EuroPCR 2026 session to better understand how lesion preparation strategies can be optimised in complex PCI using directional scoring balloon technology with DK Score Pro.

Clinical evidence is reviewed, including insights from the SCORE CHINA registry, alongside practical considerations for integrating this approach into routine...

DK Score Pro in focus: innovation, evidence, and everyday practice

Large-bore thrombectomy in pulmonary embolism practice: when intervention matters

20 May 2026 – From EuroPCR 2026

Management of pulmonary embolism is increasingly shifting toward interventional strategies, where timing, patient selection and procedural expertise play a central role in improving outcomes.

Large-bore thrombectomy is examined as a key option within contemporary PE treatment, focusing on when intervention is most appropriate and how to optimise...

Large-bore thrombectomy in pulmonary embolism practice: when intervention matters

From angiography to precision PCI: integrating ACIST Pro contrast management system and high-definition IVUS imaging

21 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session explores how advanced imaging and contrast management technologies can support a more precise and reproducible PCI workflow. The discussion focuses on the integration of the ACIST Pro contrast management system with high-definition intravascular ultrasound (IVUS) imaging to improve angiographic consistency, optimise contrast...

From angiography to precision PCI: integrating ACIST Pro contrast management system and high-definition IVUS imaging

Simplify the complex with Shockwave C2 Aero - Next-generation coronary intravascular lithotripsy that delivers

21 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session highlights the role of the next-generation Shockwave C2 Aero coronary intravascular lithotripsy system in the treatment of complex calcified coronary artery disease. Supported by real-world clinical experience and recent evidence, the discussion focuses on procedural safety, lesion preparation, and treatment consistency in...

Simplify the complex with Shockwave C2 Aero - Next-generation coronary intravascular lithotripsy that delivers

PCI of calcified distal left main stenosis - LIVE case

19 May 2026 – From EuroPCR 2026

A 54‑year‑old man with hypertension, smoking, dyslipidemia, and a history of PCI to the OM and diagonal branches in 2004 presented with a significant calcified LM–LAD stenosis.

The proximal LAD lesion was prepared with IVL followed by implantation of a 3.5 × 28 mm stent. The left...

PCI of calcified distal left main stenosis - LIVE case

The right therapy for right heart failure and tricuspid regurgitation: fixing my patient congestion, not just a valve

21 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session shifts the focus in tricuspid regurgitation from anatomy alone to the broader context of right heart failure and systemic congestion. It highlights the limitations of purely leaflet-based strategies, particularly in advanced disease and in the presence of severe right ventricular dysfunction.

The discussion...

The right therapy for right heart failure and tricuspid regurgitation: fixing my patient congestion, not just a valve

When balloons fail: how to win against coronary calcium

19 May 2026 – From EuroPCR 2026

This session refines strategies to overcome undilatable calcified coronary lesions by integrating modern calcium-modification technologies into complex PCI workflows. Through multiple international case studies, it highlights approaches to achieve optimal stent expansion despite severe coronary calcium challenges.

Aortic regurgitation in 2026

21 May 2026 – From EuroPCR 2026

Get a comprehensive overview of contemporary management strategies for aortic regurgitation, a condition that remains frequently underdiagnosed and undertreated despite significant advances in transcatheter therapies thanks to this EuroPCR 2026 session.

The programme reviews current diagnostic and treatment pathways, including guideline-based management and the role of surgical...

Aortic regurgitation in 2026

LDL-C management: should it begin in the cathlab?

21 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session examines the evolving role of LDL cholesterol management in patients undergoing percutaneous coronary intervention (PCI), with a focus on the potential benefits of initiating intensive lipid-lowering strategies early in the patient pathway.

The discussion reviews emerging evidence on PCSK9 inhibition in elective PCI...

LDL-C management: should it begin in the cathlab?

Active unloading with Impella heart pumps in elective and emergent patients

21 May 2026 – From EuroPCR 2026

This session presents the latest evidence on the use of microaxial Impella heart pumps in both elective high-risk and emergent cardiogenic shock patients. It highlights the importance of organised systems of care in improving survival outcomes and explores current data and expert consensus on mechanical circulatory...

Active unloading with Impella heart pumps in elective and emergent patients

Ascending into the future with drug-coated balloons

21 May 2026 – From EuroPCR 2026

Step into the future of interventional cardiology with comprehensive insights into drug‑coated balloons (DCB). This session covers the new DCB ARC guidelines, previews findings from the impactful BASKET BALL randomised trial, and examines real-world evidence from the SCORE registry. It also addresses the optimisation of acute...

Ascending into future with drug-coated balloons

STEMI 2026 - The precision revolution

19 May 2026 – From EuroPCR 2026

Explore the forefront of STEMI care with a focus on precision medicine, integrating artificial intelligence for pre-hospital triage, evidence-based complete revascularisation strategies, and advanced imaging guidance during primary PCI. This session also addresses tailored antithrombotic approaches, timing of mechanical support in cardiogenic shock, and management of...

Didn’t find what you were looking for?